OraSure Technologies, Inc. (OSUR)

Market Cap	283.46M
Revenue (ttm)	224.26M
Net Income (ttm)	11.37M
Shares Out	74.59M
EPS (ttm)	0.15
PE Ratio	25.16
Forward PE	64.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,258,339
Open	3.940
Previous Close	3.880
Day's Range	3.795 - 3.940
52-Week Range	3.520 - 8.040
Beta	0.05
Analysts	Hold
Price Target	5.50 (+44.74%)
Earnings Date	Feb 25, 2025

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection d...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 638
• Stock Exchange: NASDAQ
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Analyst Forecast

According to 2 analysts, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 44.74% from the latest price.

Price Target

$5.5

(44.74% upside)

Analyst Consensus: Hold